Connexin43 Hemichannel Targeting With TAT-Gap19 Alleviates Radiation-Induced Endothelial Cell Damage.

TAT-Gap19 atherosclerosis connexin43 hemichannels endothelial damage ionizing radiation

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2020
Historique:
received: 10 12 2019
accepted: 14 02 2020
entrez: 27 3 2020
pubmed: 27 3 2020
medline: 27 3 2020
Statut: epublish

Résumé

Emerging evidence indicates an excess risk of late occurring cardiovascular diseases, especially atherosclerosis, after thoracic cancer radiotherapy. Ionizing radiation (IR) induces cellular effects which may induce endothelial cell dysfunction, an early marker for atherosclerosis. In addition, intercellular communication through channels composed of transmembrane connexin proteins (Cxs), i.e. Gap junctions (direct cell-cell coupling) and hemichannels (paracrine release/uptake pathway) can modulate radiation-induced responses and therefore the atherosclerotic process. However, the role of endothelial hemichannel in IR-induced atherosclerosis has never been described before. Telomerase-immortalized human Coronary Artery/Microvascular Endothelial cells (TICAE/TIME) were exposed to X-rays (0.1 and 5 Gy). Production of reactive oxygen species (ROS), DNA damage, cell death, inflammatory responses, and senescence were assessed with or without applying a Cx43 hemichannel blocker (TAT-Gap19). We report here that IR induces an increase in oxidative stress, cell death, inflammatory responses (IL-8, IL-1β, VCAM-1, MCP-1, and Endothelin-1) and premature cellular senescence in TICAE and TIME cells. These effects are significantly reduced in the presence of the Cx43 hemichannel-targeting peptide TAT-Gap19. Our findings suggest that endothelial Cx43 hemichannels contribute to various IR-induced processes, such as ROS, cell death, inflammation, and senescence, resulting in an increase in endothelial cell damage, which could be protected by blocking these hemichannels. Thus, targeting Cx43 hemichannels may potentially exert radioprotective effects.

Sections du résumé

BACKGROUND BACKGROUND
Emerging evidence indicates an excess risk of late occurring cardiovascular diseases, especially atherosclerosis, after thoracic cancer radiotherapy. Ionizing radiation (IR) induces cellular effects which may induce endothelial cell dysfunction, an early marker for atherosclerosis. In addition, intercellular communication through channels composed of transmembrane connexin proteins (Cxs), i.e. Gap junctions (direct cell-cell coupling) and hemichannels (paracrine release/uptake pathway) can modulate radiation-induced responses and therefore the atherosclerotic process. However, the role of endothelial hemichannel in IR-induced atherosclerosis has never been described before.
MATERIALS AND METHODS METHODS
Telomerase-immortalized human Coronary Artery/Microvascular Endothelial cells (TICAE/TIME) were exposed to X-rays (0.1 and 5 Gy). Production of reactive oxygen species (ROS), DNA damage, cell death, inflammatory responses, and senescence were assessed with or without applying a Cx43 hemichannel blocker (TAT-Gap19).
RESULTS RESULTS
We report here that IR induces an increase in oxidative stress, cell death, inflammatory responses (IL-8, IL-1β, VCAM-1, MCP-1, and Endothelin-1) and premature cellular senescence in TICAE and TIME cells. These effects are significantly reduced in the presence of the Cx43 hemichannel-targeting peptide TAT-Gap19.
CONCLUSION CONCLUSIONS
Our findings suggest that endothelial Cx43 hemichannels contribute to various IR-induced processes, such as ROS, cell death, inflammation, and senescence, resulting in an increase in endothelial cell damage, which could be protected by blocking these hemichannels. Thus, targeting Cx43 hemichannels may potentially exert radioprotective effects.

Identifiants

pubmed: 32210810
doi: 10.3389/fphar.2020.00212
pmc: PMC7066501
doi:

Types de publication

Journal Article

Langues

eng

Pagination

212

Informations de copyright

Copyright © 2020 Ramadan, Vromans, Anang, Goetschalckx, Hoorelbeke, Decrock, Baatout, Leybaert and Aerts.

Références

Ann ICRP. 2012 Feb;41(1-2):1-322
pubmed: 22925378
Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):848-57
pubmed: 18514779
Int J Radiat Biol. 2006 May;82(5):309-21
pubmed: 16782648
J Cell Sci. 2004 May 1;117(Pt 11):2417-26
pubmed: 15126641
Cytometry A. 2006 Dec 1;69(12):1184-92
pubmed: 17066472
Front Immunol. 2018 Aug 15;9:1899
pubmed: 30158937
Int J Mol Sci. 2018 Mar 12;19(3):
pubmed: 29534516
J Egypt Natl Canc Inst. 2015 Dec;27(4):187-93
pubmed: 26296945
Cell Calcium. 2009 Sep;46(3):176-87
pubmed: 19656565
J Biol Chem. 2001 Mar 9;276(10):7614-20
pubmed: 11108718
Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):225-30
pubmed: 11834520
Antioxid Redox Signal. 2009 Feb;11(2):369-99
pubmed: 18816186
Cancer Res. 2003 Nov 1;63(21):7128-35
pubmed: 14612506
Oxid Med Cell Longev. 2009 Nov-Dec;2(5):259-69
pubmed: 20716913
Brain Res Bull. 2019 Mar;146:124-135
pubmed: 30593877
Exp Neurol. 2018 Feb;300:1-12
pubmed: 29055716
PLoS One. 2014 Jan 23;9(1):e86570
pubmed: 24466155
PLoS One. 2012;7(4):e35740
pubmed: 22563394
Br J Cancer. 1997;75(5):666-72
pubmed: 9043022
J Mol Cell Cardiol. 2015 Dec;89(Pt B):122-35
pubmed: 25655936
Pharmacol Rev. 2017 Oct;69(4):396-478
pubmed: 28931622
Biochem Biophys Res Commun. 2011 Nov 4;414(4):750-5
pubmed: 22001926
Int J Mol Med. 2016 Dec;38(6):1623-1641
pubmed: 27748824
World J Cardiol. 2016 Jun 26;8(6):368-74
pubmed: 27354894
Basic Res Cardiol. 2013 Jan;108(1):309
pubmed: 23184389
Cytometry A. 2010 Jan;77(1):64-75
pubmed: 19821512
FASEB J. 2010 Nov;24(11):4378-95
pubmed: 20634352
Radiat Res. 2007 Aug;168(2):193-8
pubmed: 17638405
Cell Commun Adhes. 2005 Jul-Dec;12(5-6):249-59
pubmed: 16531320
Radiat Res. 2001 Sep;156(3):232-40
pubmed: 11500132
Sci Rep. 2018 Jan 9;8(1):166
pubmed: 29317708
J Vasc Res. 2014;51(2):149-61
pubmed: 24853725
Nitric Oxide. 2006 Dec;15(4):265-79
pubmed: 16684613
J Mol Cell Cardiol. 2001 Dec;33(12):2145-55
pubmed: 11735261
Biochim Biophys Acta Mol Cell Res. 2017 Jun;1864(6):1099-1120
pubmed: 28193563
J Radiat Res. 2016 Sep;57(5):439-448
pubmed: 27422929
Cancer Lett. 2012 Dec 31;327(1-2):48-60
pubmed: 22182453
Front Cell Neurosci. 2014 Oct 21;8:306
pubmed: 25374505
Int J Radiat Biol. 2002 Aug;78(8):711-9
pubmed: 12194755
Int J Radiat Biol. 2015 Jan;91(1):1-12
pubmed: 24937368
Am J Pathol. 2006 Feb;168(2):649-58
pubmed: 16436678
Redox Biol. 2016 Oct;9:198-209
pubmed: 27567473
Exp Cell Res. 2010 Sep 10;316(15):2377-89
pubmed: 20595004
PLoS One. 2007 Aug 08;2(8):e712
pubmed: 17684558
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2045-51
pubmed: 22895665
Mutat Res Rev Mutat Res. 2015 Apr-Jun;764:90-100
pubmed: 26041268
J Orthop Res. 2013 Apr;31(4):525-30
pubmed: 23165424
Lab Invest. 2013 Jun;93(6):626-38
pubmed: 23628898
Aging Cell. 2014 Oct;13(5):900-10
pubmed: 25059316
Proteomics. 2013 Apr;13(7):1096-107
pubmed: 23349028
Glia. 2018 Aug;66(8):1788-1804
pubmed: 29683209
Mol Cell Neurosci. 2008 Oct;39(2):152-60
pubmed: 18617007
J Gerontol A Biol Sci Med Sci. 2013 Dec;68(12):1443-57
pubmed: 23689827
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):473-8
pubmed: 11149936
J Radiat Res. 2011;52(3):287-92
pubmed: 21343678
Mutat Res. 2006 May 11;597(1-2):113-8
pubmed: 16413041
J Am Heart Assoc. 2017 May 21;6(5):
pubmed: 28529208
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):214-23
pubmed: 16111592
J Cell Sci. 2006 Dec 15;119(Pt 24):5193-203
pubmed: 17158921
Cell Commun Adhes. 2003 Jul-Dec;10(4-6):395-400
pubmed: 14681047
Circulation. 2001 Sep 4;104(10):1114-8
pubmed: 11535565
Biochem Biophys Res Commun. 1995 Dec 26;217(3):784-95
pubmed: 8554599
J Exp Med. 1997 Apr 21;185(8):1481-6
pubmed: 9126928
Surg Clin North Am. 2013 Apr;93(2):455-71
pubmed: 23464696
Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H1014-21
pubmed: 20061548
J Mol Med (Berl). 2019 Feb;97(2):215-229
pubmed: 30535867
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Neurosci. 2007 Dec 12;27(50):13781-92
pubmed: 18077690
Jacobs J Radiat Oncol. 2014;1(1):
pubmed: 25614903
EJC Suppl. 2014 Jun;12(1):18-28
pubmed: 26217163
J Genet Genomics. 2014 Sep 20;41(9):485-95
pubmed: 25269674
Antioxid Redox Signal. 2009 Apr;11(4):791-810
pubmed: 18783313
Thromb Haemost. 2009 Aug;102(2):215-22
pubmed: 19652871
J Neurosci. 2017 Sep 13;37(37):9064-9075
pubmed: 28821660
J Clin Invest. 2013 Feb;123(2):540-1
pubmed: 23485580
Acta Pharmacol Sin. 2006 Jul;27(7):821-6
pubmed: 16787564
Sci Rep. 2017 Aug 15;7(1):8268
pubmed: 28811572
J Breast Cancer. 2018 Jun;21(2):206-212
pubmed: 29963117
Int J Radiat Biol. 2014 Jan;90(1):71-80
pubmed: 24164458
Cell Physiol Biochem. 2011;28(1):103-14
pubmed: 21865853
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a006429
pubmed: 22315715
JAMA Intern Med. 2015 Jun;175(6):1007-17
pubmed: 25915855
Cardiovasc Res. 2007 Oct 1;76(1):8-18
pubmed: 17617392
Prog Biophys Mol Biol. 2007 May-Jun;94(1-2):219-32
pubmed: 17462722
Cell Death Differ. 2019 Mar;26(3):580-596
pubmed: 30006609
Radiother Oncol. 2015 Nov;117(2):376-81
pubmed: 26233589
Vascul Pharmacol. 2012 May-Jun;56(5-6):216-31
pubmed: 22405985
Nat Chem Biol. 2015 Oct;11(10):807-14
pubmed: 26344695
Biochim Biophys Acta. 2013 Jan;1828(1):35-50
pubmed: 22796188
Biochem Biophys Res Commun. 2011 Jun 17;409(4):603-9
pubmed: 21600880
Bone Res. 2013 Dec 31;1(4):355-61
pubmed: 26273513
J Clin Invest. 2013 Mar;123(3):966-72
pubmed: 23454759
Radiat Res. 2016 Aug;186(2):141-52
pubmed: 27387861
Biochem Biophys Res Commun. 2014 Mar 14;445(3):549-55
pubmed: 24508803
Clin Oral Investig. 2018 Jul;22(6):2251-2262
pubmed: 29307045
Atherosclerosis. 2013 Sep;230(1):40-7
pubmed: 23958250
Cell. 2007 Jul 27;130(2):223-33
pubmed: 17662938
Biochem Pharmacol. 2016 Sep 15;116:107-19
pubmed: 27475716
Cardiol Res Pract. 2011 Feb 27;2011:317659
pubmed: 21403872
Cytokine. 1999 Nov;11(11):831-8
pubmed: 10547270
Int J Radiat Biol. 2003 Dec;79(12):955-64
pubmed: 14713573
Biochim Biophys Acta. 2013 Jan;1828(1):157-66
pubmed: 22609170
Front Pharmacol. 2017 Apr 25;8:213
pubmed: 28487652
Circulation. 2003 Feb 25;107(7):1033-9
pubmed: 12600918
Cell Mol Life Sci. 2018 Jun;75(11):2059-2073
pubmed: 29218600
Free Radic Biol Med. 2012 Jul 15;53(2):260-70
pubmed: 22580337
Cell Death Differ. 2009 Apr;16(4):524-36
pubmed: 19197295
BMJ. 2010 Jan 14;340:b5349
pubmed: 20075151
Radiat Res. 2011 Oct;176(4):474-85
pubmed: 21787183
Sci Rep. 2017 Jul 21;7(1):6134
pubmed: 28733642
BMC Cell Biol. 2017 Jan 17;18(Suppl 1):4
pubmed: 28124625
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3682-3693
pubmed: 30029255
J Immunol. 2018 Jan 15;200(2):869-879
pubmed: 29196457
Int J Radiat Biol. 2004 Apr;80(4):251-9
pubmed: 15204702
Int J Radiat Biol. 2013 Oct;89(10):841-50
pubmed: 23692394
Stem Cells. 2000;18(1):65-6
pubmed: 10661575
Trends Mol Med. 2018 Dec;24(12):1036-1053
pubmed: 30424929
BMJ. 2003 Feb 1;326(7383):256-7
pubmed: 12560277
J Pharmacol Exp Ther. 2005 Dec;315(3):1058-64
pubmed: 16144972
Neurosci Res. 2013 Mar;75(3):256-67
pubmed: 23403365
Radiat Oncol. 2013 Mar 20;8:66
pubmed: 23514369
Asia Ocean J Nucl Med Biol. 2015 Winter;3(1):3-9
pubmed: 27408875
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):506-13
pubmed: 19147015
Int J Radiat Biol. 2005 Nov;81(11):821-6
pubmed: 16484151
Redox Biol. 2015 Dec;6:260-271
pubmed: 26296072
Biochem Pharmacol. 2003 Oct 15;66(8):1661-72
pubmed: 14555247
Tex Heart Inst J. 2011;38(3):257-8
pubmed: 21720464
J Radiat Res. 2012 Jul;53(4):570-80
pubmed: 22843622
J Exp Med. 2019 Apr 1;216(4):916-935
pubmed: 30872361
Vascul Pharmacol. 2018 Jan;100:1-19
pubmed: 28579545
J Bone Miner Res. 2013 Jul;28(7):1611-21
pubmed: 23456878
Trends Mol Med. 2010 May;16(5):238-46
pubmed: 20444648
Basic Res Cardiol. 2017 May;112(3):27
pubmed: 28364353
Circulation. 2002 Mar 5;105(9):1135-43
pubmed: 11877368
Antioxid Redox Signal. 2011 Oct 1;15(7):1945-56
pubmed: 21091078
Can J Physiol Pharmacol. 2003 Jun;81(6):578-87
pubmed: 12839269
J Radiat Res. 2012 Jul;53(4):551-7
pubmed: 22843620
PLoS One. 2013 Aug 01;8(8):e70024
pubmed: 23936371
Nature. 2007 Feb 8;445(7128):656-60
pubmed: 17251933
Cell Death Differ. 2009 Jan;16(1):151-63
pubmed: 18820645
J Neurosci. 2008 Apr 30;28(18):4702-11
pubmed: 18448647
Sci Rep. 2019 Jun 20;9(1):4643
pubmed: 31217426
Mol Med Rep. 2015 Nov;12(5):7146-52
pubmed: 26324251
J Biol Chem. 2012 Apr 6;287(15):12250-66
pubmed: 22351781
Cell Commun Adhes. 2003 Jul-Dec;10(4-6):271-7
pubmed: 14681028
Biochim Biophys Acta Gen Subj. 2018 Mar;1862(3):385-393
pubmed: 29158134
Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):3961-73
pubmed: 27490318
Nat Cell Biol. 2013 Aug;15(8):978-90
pubmed: 23770676
Mutat Res Rev Mutat Res. 2016 Oct - Dec;770(Pt B):299-318
pubmed: 27919337
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
Curr Atheroscler Rep. 2017 Sep 18;19(11):42
pubmed: 28921056
J Clin Neurosci. 2008 Nov;15(11):1253-63
pubmed: 18824359
Pflugers Arch. 2010 May;459(6):897-914
pubmed: 20379740

Auteurs

Raghda Ramadan (R)

Radiobiology Unit, Belgian Nuclear Research Centre (SCK•CEN), Mol, Belgium.
Department of Fundamental and Basic Medical Sciences, Physiology Group, Ghent University, Ghent, Belgium.

Els Vromans (E)

Centre for Environmental Health Sciences, Hasselt University, Hasselt, Belgium.

Dornatien Chuo Anang (DC)

Biomedical Research Institute and Transnational University of Limburg, Hasselt University, Hasselt, Belgium.

Ines Goetschalckx (I)

Protein Chemistry, Proteomics and Epigenetic Signaling Group, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.

Delphine Hoorelbeke (D)

Department of Fundamental and Basic Medical Sciences, Physiology Group, Ghent University, Ghent, Belgium.

Elke Decrock (E)

Department of Fundamental and Basic Medical Sciences, Physiology Group, Ghent University, Ghent, Belgium.

Sarah Baatout (S)

Radiobiology Unit, Belgian Nuclear Research Centre (SCK•CEN), Mol, Belgium.
Department of Molecular Biotechnology, Ghent University, Ghent, Belgium.

Luc Leybaert (L)

Department of Fundamental and Basic Medical Sciences, Physiology Group, Ghent University, Ghent, Belgium.

An Aerts (A)

Radiobiology Unit, Belgian Nuclear Research Centre (SCK•CEN), Mol, Belgium.

Classifications MeSH